Gene therapy builds Cancer-Killing cells inside you – no lab needed
NCT ID NCT07075185
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This early-stage trial tests a new gene therapy called KLN-1010 for people with multiple myeloma that has come back or stopped responding to treatment. Instead of removing cells and engineering them in a lab, this therapy works inside the body to create special immune cells that target and attack the cancer. The study will enroll about 70 participants to check safety and find the right dose.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD PROTEIN DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
-
Emory University Hospital
RECRUITINGAtlanta, Georgia, 30322, United States
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
Contact Email: •••••@•••••
-
Peter MacCallum Cancer Centre
RECRUITINGMelbourne, Victoria, 3000, Australia
-
Providence Portland Medical Center
RECRUITINGPortland, Oregon, 97213, United States
Contact Email: •••••@•••••
-
Stanford University
RECRUITINGPalo Alto, California, 94304, United States
-
The Alfred Paula Fox Melanoma and Cancer Centre
RECRUITINGMelbourne, Victoria, 3004, Australia
-
The Royal Prince Alfred
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
UCSF
RECRUITINGSan Francisco, California, 94143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart digital program restore sleep for cancer survivors?
- Can a Two-Drug combo outsmart resistant myeloma?
- Can a Triple-Drug cocktail tame resistant myeloma?
- AI that reads faces could spot hidden distress in cancer patients
- Can a new drug combo outsmart resistant myeloma?
- Can a new pill tame psoriasis? early safety trial begins